Search Legislation

Council Decision of 16 September 1985 setting up an Advisory Committee on pharmaceutical training (85/434/EEC)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about opening options

Opening Options

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Changes over time for: Council Decision of 16 September 1985 setting up an Advisory Committee on pharmaceutical training (85/434/EEC)

 Help about opening options

Status:

Point in time view as at 31/12/2020.

Changes to legislation:

There are currently no known outstanding effects for the Council Decision of 16 September 1985 setting up an Advisory Committee on pharmaceutical training (85/434/EEC). Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

Council Decision

of 16 September 1985

setting up an Advisory Committee on pharmaceutical training

(85/434/EEC)

THE COUNCIL OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community,

Having regard to the draft Decision submitted by the Commission(1),

Whereas, in its resolution of 6 June 1974 concerning the mutual recognition of diplomas, certificates and other evidence of formal qualifications(2), the Council declared itself in favour of the establishment of advisory committees;

Whereas, in the context of the mutual recognition of diplomas, certificates and other evidence of formal qualification in pharmacy, it is important to ensure a comparably high standard of training;

Whereas, to contribute to the attainment of this objective, it is desirable to set up an Advisory Committee to advise the Commission,

HAS DECIDED AS FOLLOWS:

Article 1U.K.

An Advisory Committee on Pharmaceutical Training, hereinafter referred to as the ‘Committee’, shall be set up within the Commission.

Article 2U.K.

1.The task of the Committee shall be to help to ensure a comparably high standard of pharmaceutical training in the Community.

2.It shall carry out this task in particular by the following means:

  • exchange of comprehensive information as to the training methods and the content, level and structure of theoretical and practical courses provided in the Member States,

  • discussion and consultation with the object of developing a common approach to the standard to be attained in the training of pharmacists and, as appropriate, to the structure and content of such training,

  • keeping under review the adaptation of pharmaceutical training to developments in pharmaceutical science and teaching methods.

3.The Committee shall communicate to the Commission and the Member States its opinions and recommendations including, where it considers it appropriate, suggestions for amendments to be made to the Articles relating to pharmaceutical training in Council Directives 85/432/EEC(3) and 85/433/EEC(4).

4.The Committee shall also advise the Commission on any other matter which the Commission may refer to it in relation to pharmaceutical training.

Article 3U.K.

1.The Committee shall consist of three experts from each Member State, as follows:

  • one expert from the practising pharmaceutical profession,

  • one expert from the pharmaceutical science teaching institutions,

  • one expert from the competent authorities of the Member States.

2.There shall be an alternate for each member. Alternates may attend the meetings of the Committee.

3.The members and alternates described in paragraphs 1 and 2 shall be nominated by the Member States. The members referred to in the first and second indents of paragraph 1 and their alternates shall be nominated upon the proposal of the practising pharmaceutical profession and the pharmaceutical science teaching institutions. The members and alternates thus nominated shall be appointed by the Council.

Article 4U.K.

1.The term of office for a member of the Committee shall be three years. After the expiry of that period the members of the Committee shall remain in office until replacements have been provided for or until their appointment is renewed.

2.The term of office of a member may end before expiry of the period of three years in the event of the resignation or death of the member, or of his being replaced by another person, in accordance with the procedure laid down in Article 3. The appointment of a new member shall be for the remainder of the term of office.

Article 5U.K.

The Committee shall elect from among its members a chairman and two deputy-chairmen. It shall adopt its own rules of procedure. The agenda for meetings shall be drawn up by the chairman of the Committee in consultation with the Commission.

Article 6U.K.

The Committtee may set up working parties and call upon and allow observers or experts to assist it in connection with all the special aspects of its work.

Article 7U.K.

The secretariat of the Committee shall be provided by the Commission.

Done at Luxembourg, 16 September 1985.

For the Council

The President

M. Fischbach

(3)

See page 34 of this Official Journal.

(4)

See page 37 of this Official Journal.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources